GeoVax Applauds and Comments on Passage of $2 Trillion CARES Act
30. März 2020 09:00 ET
|
GeoVax, Inc.
Company Ready to Advance COVID-19 Vaccine Candidates to Animal Efficacy Testing, Manufacturing Scale-Up, and Human Clinical Trials ATLANTA, GA, March 30, 2020 (GLOBE NEWSWIRE) -- via...